JAK2 aberrations in childhood B-cell precursor acute lymphoblastic leukemia

JAK2 abnormalities may serve as target for precision medicines in pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL). In the current study we performed a screening for JAK2 mutations and translocations, analyzed the clinical outcome and studied the efficacy of two JAK inhibitors in pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Steeghs, Elisabeth M.P., Jerchel, Isabel S., de Goffau-Nobel, Willemieke, Hoogkamer, Alex Q., Boer, Judith M., Boeree, Aurélie, van de Ven, Cesca, Koudijs, Marco J., Besselink, Nicolle J.M., de Groot-Kruseman, Hester A., Zwaan, Christian Michel, Horstmann, Martin A., Pieters, Rob, den Boer, Monique L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5685720/
https://www.ncbi.nlm.nih.gov/pubmed/29163799
http://dx.doi.org/10.18632/oncotarget.21027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5685720/
https://www.ncbi.nlm.nih.gov/pubmed/29163799
http://dx.doi.org/10.18632/oncotarget.21027

Ejemplares similares